Gordon Duff

Sir Gordon William Duff, MA, BM MCh, PhD, MD (Hon) FFPM (Hon), FBSPharmacol (Hon), FRCP (Lon), FRCP (Edin), FMedSci, FRSE (born 27 December 1947) is a British medical scientist and academic who served (2013–14) as the Chairman of the Medicines and Healthcare Products Regulatory Agency. On 1 December 2014, he was succeeded by the current Chair, Sir Michael Rawlins.

Duff has been the Lord Florey Professor of Molecular Medicine, University of Sheffield, since 1991, and in 2014 was appointed Principal of St Hilda's College, Oxford.

Duff, the son of William Munro Duff and Marion Gertrude Duff, was educated at Perth Academy and Hipperholme Grammar School, and obtained his BA (1969) and MA (1975) degrees from St Peter's College, Oxford. He was made an Honorary Fellow of the college in 2006. Following his graduation, Duff attended St Thomas's Hospital Medical School in London, where he obtained his PhD in 1980. Following postgraduate training in London and at the RAF Medical Unit in Midhurst, he held junior faculty posts at Yale Medical School and the Howard Hughes Institute of Molecular Immunology. He joined Edinburgh Medical School in 1984, where he led the research that first identied TNF as a drug target in inflamatory diseases (now the target of drugs with multi-billion dollar sales). In 1990 he became Lord Florey Professor of Molecular Medicine at Sheffield University, where he was also Faculty Research Dean and Director of the Division of Genomic Medicine. For two years he was Chair of the UK's Medicines and Healthcare products of Regularatory Agency before taking up his current post as Principal of St Hilda's College, University of Oxford. With interests in inflammation, cytokines, biomedicines, public health and genetics, he has published many research articles and patents in these areas, as well as government reports on medicines and their regulation.

Bibliography: https://scholar.google.co.uk/citations?user=s8R73YMAAAAJ&hl=en

...
Wikipedia